Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2019 | 1 |
2020 | 2 |
2021 | 2 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Splice donor site sgRNAs enhance CRISPR/Cas9-mediated knockout efficiency.
PLoS One. 2019 May 9;14(5):e0216674. doi: 10.1371/journal.pone.0216674. eCollection 2019.
PLoS One. 2019.
PMID: 31071190
Free PMC article.
Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression.
Quijada-Álamo M, Hernández-Sánchez M, Rodríguez-Vicente AE, Pérez-Carretero C, Rodríguez-Sánchez A, Martín-Izquierdo M, Alonso-Pérez V, García-Tuñón I, Bastida JM, Vidal-Manceñido MJ, Galende J, Aguilar C, Queizán JA, González-Gascón Y Marín I, Hernández-Rivas JÁ, Benito R, Ordóñez JL, Hernández-Rivas JM.
Quijada-Álamo M, et al. Among authors: alonso perez v.
Blood Cancer J. 2021 Jul 9;11(7):127. doi: 10.1038/s41408-021-00520-5.
Blood Cancer J. 2021.
PMID: 34244476
Free PMC article.
Item in Clipboard
CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition.
Quijada-Álamo M, Hernández-Sánchez M, Alonso-Pérez V, Rodríguez-Vicente AE, García-Tuñón I, Martín-Izquierdo M, Hernández-Sánchez JM, Herrero AB, Bastida JM, San Segundo L, Gruber M, García JL, Yin S, Ten Hacken E, Benito R, Ordóñez JL, Wu CJ, Hernández-Rivas JM.
Quijada-Álamo M, et al. Among authors: alonso perez v.
Leukemia. 2020 Jun;34(6):1599-1612. doi: 10.1038/s41375-020-0714-3. Epub 2020 Jan 23.
Leukemia. 2020.
PMID: 31974435
Free PMC article.
Item in Clipboard
ETV6/RUNX1 Fusion Gene Abrogation Decreases the Oncogenicity of Tumour Cells in a Preclinical Model of Acute Lymphoblastic Leukaemia.
Montaño A, Ordoñez JL, Alonso-Pérez V, Hernández-Sánchez J, Santos S, González T, Benito R, García-Tuñón I, Hernández-Rivas JM.
Montaño A, et al. Among authors: alonso perez v.
Cells. 2020 Jan 15;9(1):215. doi: 10.3390/cells9010215.
Cells. 2020.
PMID: 31952221
Free PMC article.
Item in Clipboard
Suppression of metastatic organ colonization and antiangiogenic activity of the orally bioavailable lipid raft-targeted alkylphospholipid edelfosine.
Alonso-Pérez V, Hernández V, Calzado MA, Vicente-Blázquez A, Gajate C, Soler-Torronteras R, DeCicco-Skinner K, Sierra A, Mollinedo F.
Alonso-Pérez V, et al.
Biomed Pharmacother. 2024 Feb;171:116149. doi: 10.1016/j.biopha.2024.116149. Epub 2024 Jan 24.
Biomed Pharmacother. 2024.
PMID: 38266621
Free article.
Item in Clipboard
CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia.
Vuelta E, Ordoñez JL, Alonso-Pérez V, Méndez L, Hernández-Carabias P, Saldaña R, Sevilla J, Sebastián E, Muntión S, Sánchez-Guijo F, Hernández-Rivas JM, García-Tuñón I, Sánchez-Martín M.
Vuelta E, et al. Among authors: alonso perez v.
CRISPR J. 2021 Aug;4(4):519-535. doi: 10.1089/crispr.2021.0009.
CRISPR J. 2021.
PMID: 34406033
Item in Clipboard
The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia.
García-Tuñón I, Hernández-Sánchez M, Ordoñez JL, Alonso-Pérez V, Álamo-Quijada M, Benito R, Guerrero C, Hernández-Rivas JM, Sánchez-Martín M.
García-Tuñón I, et al. Among authors: alonso perez v.
Oncotarget. 2017 Apr 18;8(16):26027-26040. doi: 10.18632/oncotarget.15215.
Oncotarget. 2017.
PMID: 28212528
Free PMC article.
Item in Clipboard
Cite
Cite